RSV Immunisation Status in Queensland (Australia)
Recruiting
Observational Study
RSV Immunization
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,200 (estimated)
- Sponsor
- Sanofi · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary objective of this study is to determine the nirsevimab immunisation rate in eligible infants (according to Queensland Paediatric Respiratory Syncytial Virus Prevention Program recommendation) in Queensland, Australia.
The study will focus on:
1\. Assessing the immunisation rates among eligible infants (born from 1 February 2024 to 15 April 2025) in their first Respiratory Syncytial V…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Be a parent of an infant born between 1 February 2024 and 15 April 2025
* Be at least 18 years of age
* Reside in Queensland, Australia
* Read and agree to the Participant Information and Consent Form (PICF) before proceeding to the survey
* Agree with Adverse Event (AE) repor…
Contacts
Trial Transparency email recommended (Toll free for US & Canada)
800-633-1610
CONTACT